CYCN Stock Price | Cyclerion Therapeutics Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch
Cyclerion Therapeutics focuses on developing human therapeutics, specifically sGC stimulators that enhance cyclic guanosine monophosphate production. Founded in 2018, the company is based in Cambridge, MA, with a strong product pipeline in clinical development.